<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Soviet preparation of antilymphocytic globulin "Antilympholin" was used for the treatment of 24 children with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The preparation contained lymphocytotoxic antibodies and antibodies against the most important opportunistic microorganisms, thus combining the immunosuppressive and protective properties </plain></SENT>
<SENT sid="2" pm="."><plain>A single dose of "Antilympholin" was 10-15 mg/kg (10-15 transfusions), the treatment course comprised 150 mg/kg </plain></SENT>
<SENT sid="3" pm="."><plain>Infusion of haploidentical bone marrow was conducted in 14 children </plain></SENT>
<SENT sid="4" pm="."><plain>Side effects of "Antilympholin" therapy expressed in allergic reactions were recorded in 37.4% of the patients </plain></SENT>
<SENT sid="5" pm="."><plain>An early hematologic effect was achieved in 17 children (70.8%) after 1-1.5 months </plain></SENT>
<SENT sid="6" pm="."><plain>It was expressed in the elimination of hemotransfusion requirement, and in the improvement of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, platelet and neutrophil values </plain></SENT>
<SENT sid="7" pm="."><plain>Hemopoietic recovery took place only in those patients who had at least minimum residual hemopoiesis </plain></SENT>
<SENT sid="8" pm="."><plain>Late survival (according to Caplan-Meyer) comprised 62.1%, as compared to 30.6% in the control group of patients who received the hormonal therapy </plain></SENT>
<SENT sid="9" pm="."><plain>The results of "Antilympholin" application to the treatment of children with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> have evidenced its high effectiveness which is comparable with that of foreign preparations of antilymphocytic globulin </plain></SENT>
</text></document>